Related Experiment Video
Updated: Dec 6, 2025

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
Transcription factor Kruppel-like factor 5 positively regulates the expression of AarF domain containing kinase 4
Xi Chen1, Shuang Liu1, Jiahe Chen1
1Department of Pediatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing, 210029, Jiangsu, China.
Abstract:
AarF domain containing kinase 4 (ADCK4) is identified as a candidate gene associated with hereditary nephrotic syndrome (NS). Kruppel-like factor 5 (KLF5) is reported to promote podocyte survival by blocking the ERK/p38 MAPK pathways. Both ADCK4 and KLF5 are involved in the occurrence and development of podocyte disease, but their interaction remains unclear. Firstly, we found that the mRNA levels of ADCK4 and KLF5 decreased in NS patients, and both levels showed an obvious linear relationship. Secondly, we cloned the ADCK4 promoter region and examined its promoter activity in Hela, A549, and HEK 293 cell lines. Deletion analysis showed that the region - 116/- 4 relative to the transcriptional start site (TSS) was the core region of ADCK4 promoter. Thirdly, mutation analysis showed that putative binding sites for KLF5 contributed to the ADCK4 promoter activity. In HEK293 cells, we found that KLF5 upregulated the mRNA and protein levels of ADCK4. Finally, our chromatin immunoprecipitation assay found that KLF5 could bind to the specific region of ADCK4 promoter. These results showed that KLF5 can positively regulate the transcriptional activity of ADCK4.
Insights
Kruppel-like factor 5 (KLF5) upregulates AarF domain containing kinase 4 (ADCK4) in nephrotic syndrome (NS) podocyte disease. KLF5 binds to the ADCK4 promoter, increasing its transcriptional activity and expression.
Area of Science:
- Molecular Biology
- Genetics
- Nephrology
Background:
- AarF domain containing kinase 4 (ADCK4) and Kruppel-like factor 5 (KLF5) are implicated in podocyte disease.
- The precise interaction between ADCK4 and KLF5 in nephrotic syndrome (NS) pathogenesis is not well understood.
Purpose of the Study:
- To investigate the regulatory relationship between KLF5 and ADCK4 in the context of NS.
- To determine if KLF5 influences ADCK4 expression and activity.
Main Methods:
- Analysis of ADCK4 and KLF5 mRNA levels in NS patients.
- Cloning and functional analysis of the ADCK4 promoter region using deletion and mutation studies in cell lines (Hela, A549, HEK 293).
- Chromatin immunoprecipitation (ChIP) assay to confirm KLF5 binding to the ADCK4 promoter.
Main Results:
- ADCK4 and KLF5 mRNA levels were decreased and linearly correlated in NS patients.
- Deletion analysis identified a core ADCK4 promoter region (-116/-4 relative to TSS).
- KLF5 binding sites within the ADCK4 promoter were critical for its activity, with KLF5 upregulating ADCK4 mRNA and protein levels in HEK293 cells. ChIP confirmed KLF5 binding to the ADCK4 promoter.
Conclusions:
- KLF5 positively regulates the transcriptional activity of ADCK4.
- This interaction suggests a novel molecular mechanism in the development of podocyte disease and nephrotic syndrome.
More Related Videos
Related Concept Videos
Master Transcription Regulators
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Transcription Factors
General Transcription Factors
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

